FOLH1 and prostate cancer: PET with 68Ga-PSMA demonstrated a superior tumour-to-background signal intensity and substantially higher detection rates than have been previously reported for other imaging modalities in patients with newly diagnosed [12–15] or recurrent [3, 16–20] prostate cancer.